| 1 |
Prolonged siRNA expression in mammalian cells using an Epstein-Barr virus-based plasmid expression system
Wu Y, Song TQ, Chen PP, Jiang XH, Wang Q, Chen QH
Biochemical and Biophysical Research Communications, 529(1), 51, 2020 |
| 2 |
Investigation of relationship between EBNA-1 expression level and specific foreign protein productivity in transient gene expression of HEK293 cells
Lee JH, Lim SM, Park SH, Min JK, Lee GM, Kim YG
Process Biochemistry, 55, 182, 2017 |
| 3 |
An EBV-Based Plasmid Can Replicate and Maintain in Stem Cells
Rad SMAH, Bamdad T, Arefian E, Mossahebi-Mohammadi M, Sadeghizadeh M
Biotechnology Progress, 31(6), 1579, 2015 |
| 4 |
EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1
Chen YL, Tsai HL, Peng CW
Biochemical and Biophysical Research Communications, 417(3), 1093, 2012 |
| 5 |
Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization
Kim SY, Song KA, Kieff E, Kang MS
Biochemical and Biophysical Research Communications, 424(2), 251, 2012 |
| 6 |
Development of apoptosis-resistant CHO cell line expressing PyLT for the enhancement of transient antibody production
Kim WH, Kim MS, Kim YG, Lee GM
Process Biochemistry, 47(12), 2557, 2012 |
